Search form



CL Mobile Menu

Payal Kohli, MD

Payal Kohli, MD

Dr Kohli is a graduate of Harvard Medical School, where she received a magna cum laude distinction. She completed a residency in Internal Medicine at Harvard Medical School/Brigham & Women’s hospital and a fellowship in cardiovascular diseases at the University of California San Francisco. Currently she is in practice with a cardiovascular medicine group in Denver, Colorado.




Posts by Author

Which drugs taken concurrently with the new oral anticoagulants put patients with Afib at greatest increased risk for major bleeding?

Copyright Tribalium/

A first-of-its-kind study reports an association between T1DM and AF, and between glycemic control and AF. Plus, there are gender differences.

That depends, as suggested by results of the CASTLE-AF study, presented at ESC Congress 2017, in Barcelona, Spain.

Diagnosis of atrial fibrillation via handheld iECG monitor looks promising but can we pay for it yet?

A small study raises big questions about patients' perceptions of AF symptoms after pulmonary vein ablation. What do you think?

Increased detection of subclinical atrial fibrillation intensifies a common clinical quandary in AF patients: to anticoagulate, or not?

Rhythm vs rate control and which medication(s) for which patients, when, and why? Test yourself.

Medicine is finally catching up with the smartphone/smartwatch era – and it’s about time!

Does coffee increase AF risk? How about chocolate? Marijuana? Test yourself with our quiz so you can counsel your patients.

Mr Smith is 66-years-old. How would you treat his arrhythmia? What would you choose for anticoagulation?


By clicking Accept, you agree to become a member of the UBM Medica Community.